Top Markets
Coin of the day
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH
Rangering i aksjer #26771
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Aksjekurs
$28.27
Sist synkronisert: 2026-08-11
Markedsverdi
$37.93M
Endring (1 dag)
-1.07%
Endring (1 år)
255.09%
Land
US
Handel Faeth Therapeutics, Inc. (FTH)

Kategori

Utbytteavkastning for Faeth Therapeutics, Inc. (FTH)
Faeth Therapeutics, Inc. (aksjesymbol: FTH) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Faeth Therapeutics, Inc. (FTH) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH